Africa: Promising New Tuberculosis Drug Approved, but Will It Be Affordable?

[MSF] Geneva/New York - M édecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB).
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news